Don Nguyen Vo
Examiner (ID: 1239, Phone: (571)272-3018 , Office: P/2634 )
Most Active Art Unit | 2634 |
Art Unit(s) | 2631, 2634, 2734, 1609, 2614, 2611, 2636 |
Total Applications | 2723 |
Issued Applications | 2252 |
Pending Applications | 276 |
Abandoned Applications | 195 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17251393
[patent_doc_number] => 11186870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-30
[patent_title] => FRET-labeled compounds and uses therefor
[patent_app_type] => utility
[patent_app_number] => 16/773519
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21511
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773519
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773519 | FRET-labeled compounds and uses therefor | Jan 26, 2020 | Issued |
Array
(
[id] => 18274838
[patent_doc_number] => 11613772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => High intensity labeled reactant compositions and methods for sequencing
[patent_app_type] => utility
[patent_app_number] => 16/751138
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 29360
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751138
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751138 | High intensity labeled reactant compositions and methods for sequencing | Jan 22, 2020 | Issued |
Array
(
[id] => 17060344
[patent_doc_number] => 11104934
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Quantitative assessment for cap efficiency of messenger RNA
[patent_app_type] => utility
[patent_app_number] => 16/744985
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15765
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744985 | Quantitative assessment for cap efficiency of messenger RNA | Jan 15, 2020 | Issued |
Array
(
[id] => 18701448
[patent_doc_number] => 11787947
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Dyes in dye aggregate systems--engineering J, K, and dye packing
[patent_app_type] => utility
[patent_app_number] => 16/739963
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 33
[patent_no_of_words] => 15290
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739963 | Dyes in dye aggregate systems--engineering J, K, and dye packing | Jan 9, 2020 | Issued |
Array
(
[id] => 16817080
[patent_doc_number] => 11001888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Short pendant arm linkers for nucleotides in sequencing applications
[patent_app_type] => utility
[patent_app_number] => 16/732664
[patent_app_country] => US
[patent_app_date] => 2020-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 10203
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16732664
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/732664 | Short pendant arm linkers for nucleotides in sequencing applications | Jan 1, 2020 | Issued |
Array
(
[id] => 15769459
[patent_doc_number] => 20200115747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => LABELLED NUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 16/726040
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16726040
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/726040 | LABELLED NUCLEOTIDES | Dec 22, 2019 | Abandoned |
Array
(
[id] => 16157317
[patent_doc_number] => 20200216891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => NUCLEOSIDES AND NUCLEOTIDES WITH 3'-HYDROXY BLOCKING GROUPS
[patent_app_type] => utility
[patent_app_number] => 16/724088
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/724088 | Sequencing methods using nucleotides with 3' AOM blocking group | Dec 19, 2019 | Issued |
Array
(
[id] => 17045184
[patent_doc_number] => 11098353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
[patent_app_type] => utility
[patent_app_number] => 16/722702
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 12
[patent_no_of_words] => 15590
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 436
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722702
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/722702 | Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators | Dec 19, 2019 | Issued |
Array
(
[id] => 16157315
[patent_doc_number] => 20200216890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => Method for Sequencing a Polynucleotide
[patent_app_type] => utility
[patent_app_number] => 16/723315
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/723315 | Method for Sequencing a Polynucleotide | Dec 19, 2019 | Abandoned |
Array
(
[id] => 18701431
[patent_doc_number] => 11787930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Flow cell including a heteropolymer
[patent_app_type] => utility
[patent_app_number] => 16/721451
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 19040
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721451
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721451 | Flow cell including a heteropolymer | Dec 18, 2019 | Issued |
Array
(
[id] => 16893428
[patent_doc_number] => 11034964
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-15
[patent_title] => Binding molecules built from L-DNA with added nucleotides
[patent_app_type] => utility
[patent_app_number] => 16/719232
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3798
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/719232 | Binding molecules built from L-DNA with added nucleotides | Dec 17, 2019 | Issued |
Array
(
[id] => 15866147
[patent_doc_number] => 20200140477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/714595
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16714595
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/714595 | Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway | Dec 12, 2019 | Issued |
Array
(
[id] => 16177289
[patent_doc_number] => 20200224257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => QUENCHER AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/700618
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 378
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/700618 | Quencher and use thereof | Dec 1, 2019 | Issued |
Array
(
[id] => 15649613
[patent_doc_number] => 20200087336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => LABELLED NUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 16/691108
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691108
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/691108 | LABELLED NUCLEOTIDES | Nov 20, 2019 | Abandoned |
Array
(
[id] => 15931959
[patent_doc_number] => 20200157613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => CHROMOGENIC PEROXIDASE SUBSTRATES
[patent_app_type] => utility
[patent_app_number] => 16/688076
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/688076 | Chromogenic peroxidase substrates | Nov 18, 2019 | Issued |
Array
(
[id] => 15711153
[patent_doc_number] => 20200102342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/687356
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16687356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/687356 | Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway | Nov 17, 2019 | Issued |
Array
(
[id] => 15590441
[patent_doc_number] => 20200071755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => Methods and Compositions for Incorporating Nucleotides
[patent_app_type] => utility
[patent_app_number] => 16/674341
[patent_app_country] => US
[patent_app_date] => 2019-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16674341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/674341 | Methods and compositions for incorporating nucleotides | Nov 4, 2019 | Issued |
Array
(
[id] => 17292588
[patent_doc_number] => 20210388427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => LIQUID SAMPLE WORKFLOW FOR NANOPORE SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 17/291804
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291804 | LIQUID SAMPLE WORKFLOW FOR NANOPORE SEQUENCING | Oct 28, 2019 | Pending |
Array
(
[id] => 16230534
[patent_doc_number] => 10738072
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-08-11
[patent_title] => Nucleotide analogues
[patent_app_type] => utility
[patent_app_number] => 16/662781
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 77560
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16662781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/662781 | Nucleotide analogues | Oct 23, 2019 | Issued |
Array
(
[id] => 17258951
[patent_doc_number] => 20210371936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => PREDICTIVE METHODS IN BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/291224
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291224 | PREDICTIVE METHODS IN BREAST CANCER | Oct 22, 2019 | Pending |